Kleefstra syndrome is a rare genetic condition that affects development and learning. People with Kleefstra syndrome often have delayed speech, low muscle tone, and intellectual disability, and doctors may see distinctive facial features. Many also have sleep problems, behavioral differences, or congenital heart or kidney issues, but not everyone will have the same experience. It is lifelong, usually recognized in infancy or early childhood, and confirmed with genetic testing. Care focuses on supportive therapies, managing medical issues, and regular follow-up, and the outlook varies but many people live long and full lives.
Overview
Kleefstra syndromeSymptoms
Kleefstra syndrome features low muscle tone, feeding problems in infancy, slow motor and speech development, and learning disability. Early signs of Kleefstra syndrome may include distinctive facial traits, sleep problems, autism-like behaviors, seizures, and occasionally heart or kidney defects.
Outlook and prognosis
Many people with Kleefstra syndrome make steady gains in communication, mobility, and daily skills with early therapies and school supports. Medical needs vary; heart, sleep, and seizure issues are often manageable. Most require lifelong assistance, but quality of life can be good.
Causes and risk factors
Kleefstra syndrome stems from loss of EHMT1 function, usually from a 9q34.3 deletion or an EHMT1 variant. Most cases are de novo; risk rises with an affected parent or parental rearrangement. Environment and lifestyle don’t cause it.
Genetic influences
Genetics is central in Kleefstra syndrome: most cases arise from a change or deletion in the EHMT1 gene. These variations disrupt brain development and can influence learning, speech, behavior, sleep, and growth. Inheritance is usually de novo, but familial transmission can occur.
Diagnosis
Diagnosis of Kleefstra syndrome starts with clinical features and developmental history. Genetic tests—chromosomal microarray and single-gene sequencing—confirm the genetic diagnosis of Kleefstra syndrome; imaging or other studies may check associated features.
Treatment and drugs
Treatment for Kleefstra syndrome focuses on building skills, supporting development, and managing specific health needs. Care often includes early therapies (speech, physical, occupational), educational supports, sleep and behavior strategies, seizure control, and monitoring heart, breathing, and feeding issues. Regular follow-up with genetics, neurology, cardiology, ENT, and dental teams helps adjust care over time.
Symptoms
Living with Kleefstra syndrome often means differences in development, communication, and muscle tone that shape daily routines. Features vary from person to person and can change over time. If you’re looking for early features of Kleefstra syndrome, families often first notice low muscle tone and feeding challenges in the first months of life. Over time, delays in speech, learning, and movement often come into focus.
Many children reach sitting, crawling, and walking later than peers. With therapies, skills usually improve over time. The range of delay can be mild to more significant.
Words may come late, and some people speak only a few words or remain nonverbal. Understanding is often stronger than speaking. Communication supports can be key in Kleefstra syndrome.
Babies can feel floppy when held, and muscles tire easily. Clinicians call this hypotonia, which means the muscles provide less support than usual. It can affect feeding, posture, and coordination.
Early on, weak suck or swallowing trouble can make feeding slow. Reflux or poor weight gain may occur. Feeding therapy, thickened feeds, or short-term tube support can help.
How people usually first notice Kleefstra syndrome?
Many families first notice Kleefstra syndrome in early infancy when a baby seems unusually quiet or sleepy, has weak muscle tone, and struggles with feeding or gaining weight. As months pass, doctors and caregivers may see developmental delays—like sitting, babbling, or walking later than peers—along with distinctive facial features and sometimes small congenital issues such as heart or kidney differences. For many, the “first signs of Kleefstra syndrome” come together during early check-ups when these delays and features prompt genetic testing to look for changes involving the EHMT1 gene.
Types of Kleefstra syndrome
Kleefstra syndrome can look a little different from one person to the next. Most cases are caused by a small missing piece of chromosome 9, while others come from a change within the EHMT1 gene itself; both affect the same biological pathway but can lead to differences in severity and learning needs. People may notice different sets of symptoms depending on their situation. When people look up types of Kleefstra syndrome, they’re usually referring to these two well-recognized genetic variants.
9q34.3 deletion
A tiny missing segment on chromosome 9 that includes EHMT1. This variant often has more pronounced developmental delays and medical features because multiple neighboring genes can be affected. Speech, muscle tone, and congenital issues may be more impacted.
EHMT1 sequence variant
A change within the EHMT1 gene without losing nearby genes. Many share the core features of Kleefstra syndrome but may have milder or more variable medical findings. Learning and communication differences can still be significant.
What genetics can tell you about symptoms
Some people with Kleefstra syndrome who have a deletion on chromosome 9 (including the EHMT1 gene) often show more pronounced developmental delay, low muscle tone, and distinctive facial features. When there’s a single EHMT1 gene mutation instead, speech delay, autism traits, and sleep problems may be more prominent.
Causes and risk factors
Kleefstra syndrome is usually caused by a new change in the EHMT1 gene or a small missing piece on chromosome 9. Most cases are not inherited, but it can rarely be passed down by a parent who carries the change or a chromosome rearrangement. If a parent has the EHMT1 change, each child has a 50% chance to inherit it. Genes set the stage, but environment and lifestyle often decide how the story unfolds. In practice, risk factors for Kleefstra syndrome are mainly genetic, while medical care, therapies, and daily supports can influence how features show up.
Environmental and biological risk factors
Most cases of Kleefstra syndrome begin very early in development and are not caused by anything parents did or did not do. When people ask about early risk factors for Kleefstra syndrome, it helps to think about influences that come from within the body and from the world around us. Doctors often group risks into internal (biological) and external (environmental). Below are factors researchers consider when looking at how rare, chance changes can arise before or during pregnancy.
Random changes can occur when eggs or sperm form, or in the first days after conception. These rare events can lead to the chromosome change behind Kleefstra syndrome. They are not linked to anything a parent did.
As fathers get older, new changes in sperm become slightly more common. This may modestly raise the chance of a new change related to Kleefstra syndrome, though the overall risk stays very low. Most children born to older fathers are healthy.
Aging eggs have a higher chance of chromosome errors. While this mainly affects whole chromosomes rather than small deletions, overall risk of new changes in the embryo rises slightly with age. Evidence for effects on small deletions is mixed.
Strong ionizing radiation to a parent’s pelvis before conception or to the uterus very early in pregnancy can damage DNA. At high levels, this can increase the chance of new chromosome breaks or deletions. Routine imaging like standard X-rays uses far lower doses.
Genetic risk factors
The genetic causes of Kleefstra syndrome usually involve a change in one copy of the EHMT1 gene or a tiny missing segment on chromosome 9q34.3 that includes this gene. Most cases arise as a new change in the child rather than being inherited, though a minority relate to a parent’s balanced chromosome rearrangement or rarely to mosaicism. People with the same risk factor can have very different experiences.
EHMT1 gene changes: A change that switches off or weakens one copy of the EHMT1 gene disrupts its role in controlling other genes. This loss of function is the main driver of Kleefstra syndrome. Different types of changes can have similar effects.
9q34.3 microdeletion: Some people have a microdeletion—a small missing piece—at 9q34.3 that removes EHMT1. The deletion may also remove nearby genes, which can shape features beyond the core signs of Kleefstra syndrome. Size of the deletion does not always predict severity.
De novo changes: In most families, the EHMT1 change happens for the first time in the child (de novo). Parents typically do not carry or pass down the change. This helps explain why Kleefstra syndrome often appears without a prior family history.
Autosomal dominant pattern: A change in just one copy of EHMT1 is enough to cause the condition. An adult living with Kleefstra syndrome has a 50% chance in each pregnancy to pass on the altered gene. Severity in a child can differ from the parent.
Balanced rearrangement: Rarely, a parent has a balanced chromosome rearrangement that places 9q34.3 at risk during egg or sperm formation. This can lead to a child with a deletion that includes EHMT1. The parent may be healthy because no genetic material is missing or extra in their own cells.
Germline mosaicism risk: Even if parents’ blood tests are normal, a small fraction of their egg or sperm cells can carry the EHMT1 change. This creates a small but real chance of another child with Kleefstra syndrome. Standard blood testing may not detect this low-level mosaicism.
Child mosaicism: Occasionally, only some of a child’s cells carry the EHMT1 change (mosaicism). This can lead to milder or atypical features, and patterns vary. Mosaicism does not remove the possibility of passing on the change if reproductive cells are involved.
Recurrence risk: If neither parent carries the change or a rearrangement, the chance of another affected child is low—usually less than 1–2% because of possible germline mosaicism. If a parent is affected or carries the EHMT1 change, the chance is 50% in each pregnancy. Genetic counseling can help clarify family-specific risks.
Lifestyle risk factors
Kleefstra syndrome is a genetic condition; lifestyle habits do not cause it, but they can influence symptoms, day-to-day function, and complications. Understanding how lifestyle affects Kleefstra syndrome can help families target routines that support development, sleep, behavior, and cardiometabolic health. The elements below focus on lifestyle risk factors for Kleefstra syndrome and how daily choices may help or hinder outcomes.
Regular, adapted movement strengthens low muscle tone and improves balance, endurance, and bone health. Sedentary routines can worsen constipation, weight gain, sleep problems, and deconditioning.
A balanced, fiber-rich, texture-appropriate diet supports growth and helps manage reflux and constipation. High-sugar, ultra-processed foods can drive unhealthy weight gain and metabolic risk in the setting of hypotonia and lower energy needs.
Safe-swallow techniques, pacing, and appropriate textures reduce choking, aspiration, and mealtime distress. Rushed meals or inappropriate textures can worsen reflux, aversion, and respiratory complications.
Consistent schedules and calming bedtime routines can improve attention, learning, and daytime behavior, and may lower seizure risk in those with epilepsy. Irregular or insufficient sleep often increases irritability, inattention, and self-injury.
Risk prevention
Kleefstra syndrome is genetic, so you can’t prevent it from occurring, but you can lower the risk of complications and support healthy development. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. Early, coordinated care helps with learning, behavior, breathing, sleep, and nutrition. Plans should be tailored over time, since needs can change with age.
Meet with a genetics professional to understand inheritance and reproductive options. This can include planning for prenatal or preimplantation testing in future pregnancies.
Get prompt assessments for development, speech, and behavior. Recognizing early symptoms of Kleefstra syndrome can speed referrals and therapies.
Keep immunizations up to date to prevent serious infections. Ask about flu and pneumococcal shots if your child with Kleefstra syndrome has lung or heart issues.
Treat ear, sinus, and chest infections early to protect breathing and sleep. Good hand hygiene and timely medical care help lower complications in Kleefstra syndrome.
Transmission
Kleefstra syndrome is not contagious—you can’t catch it or pass it through everyday contact. It happens because of a change, or a very small missing piece, in a gene important for development, and in most families this change is new in the child.
Parents who don’t carry the change usually have a low chance of it happening again, though a small risk remains if some egg or sperm cells carry the change. If a parent does have the same genetic change, each pregnancy has a 1 in 2 (50%) chance to inherit Kleefstra syndrome. A genetics professional can explain the genetic transmission of Kleefstra syndrome and discuss testing options for parents, siblings, and future pregnancies.
When to test your genes
Consider genetic testing if a child shows global developmental delay, low muscle tone, distinctive facial features, or congenital issues (heart, kidneys), especially when standard evaluations are inconclusive. Testing is also appropriate for people with autism traits plus intellectual disability, or a family history of chromosome 9q34 changes. Results can confirm Kleefstra syndrome, guide tailored therapies, and inform family planning.
Diagnosis
When doctors suspect Kleefstra syndrome based on developmental delays, low muscle tone, and a recognizable facial pattern, they confirm it with specific genetic tests. The genetic diagnosis of Kleefstra syndrome is confirmed by finding a change in the EHMT1 gene or a small missing piece on chromosome 9q34.3. Genetic testing may be offered to clarify risk or guide treatment. Timing varies; some children are identified in infancy while others are diagnosed later as the pattern becomes clearer.
A genetics-trained clinician looks for a consistent pattern of findings such as hypotonia, developmental delay, and facial features. These clinical features guide which genetic tests to order.
A three-generation family history helps check for similar features or known genetic results. Most cases are new (de novo), but inherited cases can occur.
This test looks for small missing or extra pieces of chromosomes across the genome. It can detect a 9q34.3 deletion that includes EHMT1 and confirms Kleefstra syndrome.
This analyzes the EHMT1 gene letter by letter to find small changes. It helps diagnose Kleefstra syndrome when microarray does not show a deletion.
Stages of Kleefstra syndrome
Kleefstra syndrome does not have defined progression stages. It’s a lifelong neurodevelopmental condition where needs and abilities vary from person to person, and early symptoms of Kleefstra syndrome—like low muscle tone, feeding difficulties, and delayed speech—tend to emerge in infancy or early childhood rather than unfolding in set steps. Different tests may be suggested to help understand learning, speech, heart, hearing, or sleep needs, but diagnosis is confirmed by genetic testing that finds a change in the EHMT1 gene or a small missing piece at 9q34.3. Ongoing care usually includes regular developmental check-ins and medical follow-ups to monitor growth, behavior, seizures, and other health features.
Outlook and prognosis
Looking ahead can feel daunting, but many people with Kleefstra syndrome continue to make steady gains with the right mix of therapies and school supports. Development usually progresses slowly over time—speech and motor skills often improve into adolescence and adulthood, though most people need ongoing assistance with learning and daily tasks. Seizures, sleep problems, anxiety, or autistic features can appear at different ages; early symptoms of Kleefstra syndrome can be subtle and sometimes aren’t recognized until school years.
The outlook is not the same for everyone, but most people with Kleefstra syndrome have a stable life expectancy, especially with good medical care and monitoring. Serious medical complications are uncommon overall, though congenital heart defects, significant breathing problems, or uncontrolled seizures—when present—can raise health risks. Some people experience periods when behavior or sleep worsens, while others notice long stretches of stability; addressing hearing, vision, pain, constipation, and reflux can prevent setbacks that look like regression. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
With ongoing care, many people maintain good quality of life into adulthood, and families often report meaningful progress in communication, social connection, and independence with routines. Support from friends and family can strengthen mental health, reduce caregiver strain, and help stick with therapies during tougher phases. Talk with your doctor about what your personal outlook might look like, including how to plan for adult services, guardianship or supported decision-making, and transition to adult medical care.
Long-term effects
Daily life is often shaped by ongoing developmental and health needs, from learning and communication to sleep and energy. The long-term outlook for Kleefstra syndrome depends on which features are present and how strongly they affect learning, health, and independence. Long-term effects vary widely across childhood, adolescence, and adulthood. Many grow steadily over time, though support needs often continue into adult life.
Intellectual disability typically ranges from mild to more significant and tends to be lifelong. Many make gradual gains with age, though skills can plateau at times. Adult independence usually requires ongoing support.
Speech is often delayed or limited, while understanding is usually stronger than speaking. Some rely more on gestures, expressions, or devices to communicate. Social reciprocity can be affected by language challenges.
Low muscle tone and coordination differences can delay walking and make fine motor tasks harder. Endurance may be reduced, and activities that need balance can be challenging. These features often persist into adulthood.
Many show traits linked with autism, such as repetitive behaviors and social communication differences. Attention and impulse control challenges can occur. Emotional regulation may be harder during transitions or stress.
How is it to live with Kleefstra syndrome?
Living with Kleefstra syndrome often means balancing developmental and learning differences with medical follow-up, like support for low muscle tone, sleep issues, feeding challenges in infancy, and later speech and behavioral therapies. Daily life tends to involve structured routines, visual supports, and coordinated care from therapists and educators, which can help many build communication, self-care, and social skills over time. Families and caregivers are deeply involved, experiencing both extra logistics and stress as well as meaningful progress milestones, and they often benefit from respite care and community connections. Friends, classmates, and extended family can make a real difference by offering patience, clear communication, and inclusive activities that match the person’s pace and sensory comfort.
Treatment and drugs
Treatment for Kleefstra syndrome focuses on easing symptoms, building skills, and supporting development over time. Most care plans include early intervention therapies such as speech and language therapy (often with augmentative communication), physical and occupational therapy, and educational supports; behavioral therapies can help with attention, anxiety, and sleep routines. Doctors sometimes recommend a combination of lifestyle changes and drugs, for example using melatonin or sleep hygiene for sleep problems, anti‑seizure medicines if seizures occur, and targeted treatments for reflux, constipation, or breathing issues. Regular check-ins with a team—neurology, cardiology, ENT, dentistry, genetics, and mental health—help monitor growth, hearing and vision, heart structure, breathing during sleep, and dental health, adjusting care as needs change. Although living with Kleefstra syndrome can feel overwhelming, supportive care can make a real difference in how you feel day to day.
Non-drug treatment
For Kleefstra syndrome, non-drug care focuses on building everyday skills—communication, movement, learning, feeding, sleep, and behavior—so life is safer and more independent. Non-drug treatments often lay the foundation for progress at home, school, and in the community. Starting support early, especially when early symptoms of Kleefstra syndrome are noticed, can make a meaningful difference. A coordinated team approach helps tailor therapy to each person’s strengths and challenges.
A coordinated plan brings key therapies in during infancy and preschool years. Regular sessions help steady progress and guide families on home activities.
Targeted exercises build core strength, balance, and coordination to address low muscle tone. Therapists also work on posture, walking, and safe movement.
Practice with hand skills and daily routines supports dressing, feeding, and play. Therapists also help with sensory processing and adapting tasks to reduce fatigue.
Sessions build understanding, sound production, and social communication. Oral-motor work can support chewing and swallowing skills.
Your genes may have an impact on how drugs work for you
Medicines used in Kleefstra syndrome can work differently from person to person because gene changes may affect how the body absorbs, breaks down, or responds to drugs. Genetic testing and careful dose adjustments can help clinicians choose safer, more effective treatments.
Pharmacological treatments
Medicines for Kleefstra syndrome focus on specific issues like sleep, behavior, attention, seizures, reflux, and constipation. While medicines don’t change early symptoms of Kleefstra syndrome, they can ease day-to-day challenges and support therapies such as speech and occupational therapy. Drugs that target symptoms directly are called symptomatic treatments. Choices are individualized based on age, health, and how someone responds.
Melatonin at bedtime can help reset sleep timing and improve total sleep. If needed, clonidine or trazodone may be added for falling or staying asleep; morning grogginess can occur.
Risperidone or aripiprazole can lower irritability, aggression, or self-injury. Doctors monitor for weight gain, blood sugar or cholesterol changes, and rare movement effects.
Methylphenidate or lisdexamfetamine may improve attention, hyperactivity, and impulsivity. Guanfacine or atomoxetine are alternatives if stimulants worsen appetite, anxiety, or tics. Dosing may be increased or lowered gradually to balance benefits and side effects.
Sertraline or fluoxetine can ease anxiety, repetitive worries, and low mood. Starting with a low dose and increasing slowly helps limit stomach upset, restlessness, or sleep changes.
Genetic influences
In most people, Kleefstra syndrome happens because one copy of a gene called EHMT1 on chromosome 9 is missing or doesn’t work as it should. This single-copy loss changes how the brain and body develop, and it usually occurs as a new change in the child rather than being inherited from a parent. In a smaller number of families, the EHMT1 change can be passed down; one changed copy is enough to cause the condition, and a parent may have very mild signs or carry the change in only some egg or sperm cells. DNA testing can sometimes identify these changes. When early symptoms of Kleefstra syndrome raise concern, finding the specific EHMT1 change can confirm the diagnosis and help estimate the chance of it happening again in the family. Because causes and inheritance can differ (a small missing piece of chromosome 9 versus a change within the gene), a genetics team can explain what your results mean for care and future pregnancies.
Is Kleefstra syndrome genetic?
Genetics is central in Kleefstra syndrome: most cases arise from a change or deletion in the EHMT1 gene. These variations disrupt brain development and can influence learning, speech, behavior, sleep, and growth. Inheritance is usually de novo, but familial transmission can occur.
Pharmacogenetics—how genetics influence drug effects
Most medicines used in Kleefstra syndrome aim to manage symptoms—like seizures, sleep problems, anxiety, mood, or attention—rather than target the underlying gene change. Genetic testing can sometimes identify how your body processes certain medicines, helping doctors choose a starting dose and avoid side effects. Common differences in drug‑processing enzymes can make some people break down many antidepressants, some antipsychotics, and several anti‑seizure medicines more slowly or very quickly, which can change how well they work and the chance of sedation, irritability, or other reactions. The EHMT1 change that causes Kleefstra syndrome doesn’t currently point to a specific medication, but it can sit alongside these typical drug–gene differences, so results used for the general population still apply. While early symptoms of Kleefstra syndrome such as low muscle tone and feeding challenges are often treated mainly with therapies and supports, later use of sleep aids, anti‑seizure drugs, or behavioral medicines can be tailored with this information. Your care team will also consider age, body size, other health conditions, and all current prescriptions so that medication response in Kleefstra syndrome is as personalized and safe as possible.
Interactions with other conditions
People with Kleefstra syndrome often live with other health issues that affect daily life, such as autism spectrum features, epilepsy, sleep apnea, constipation, or heart differences. Doctors call it a “comorbidity” when two conditions occur together. Early symptoms of Kleefstra syndrome, such as low muscle tone and feeding difficulties, can overlap with reflux or aspiration, and frequent ear infections or hearing loss may further delay speech and learning.
These conditions can influence one another. Poor sleep from apnea can worsen daytime behavior or lower the seizure threshold, while constipation or reflux can heighten irritability and feeding challenges. Some medicines used for behavior or seizures may add sleepiness, weight gain, or constipation, which can make apnea or gut symptoms harder to manage. Talk with your doctor about how your conditions may influence each other so treatments can be coordinated and adjusted over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who developed more slowly, spoke later than peers, and needed extra support to learn daily skills. Families and teachers noticed patterns across generations but rarely had a name to connect those shared experiences. Medical notes from the mid‑to‑late 20th century began to group these features together—developmental delays, low muscle tone, distinct facial features, and sometimes sleep or behavior differences—but the cause remained unclear for many years.
First described in the medical literature as a recognizable pattern in the 1990s, the condition was later linked to changes on chromosome 9. As medical science evolved, researchers noticed that a tiny missing piece (a microdeletion) in a specific region of chromosome 9q34 explained many cases that looked similar in clinics worldwide. Soon after, studies found that a change in a single gene within that region, called EHMT1, could lead to the same set of features. This shift—from describing a pattern to pinpointing a gene—marked a turning point in understanding the history of Kleefstra syndrome.
In recent decades, knowledge has built on a long tradition of observation. Early reports focused on what clinicians could see: slower motor milestones, limited speech, and characteristic facial traits. Genetic testing then connected these outward signs to a common biological cause. With that connection, previously separate case reports were recognized as part of the same condition, which helped families find clearer answers and more consistent guidance.
Over time, descriptions became more nuanced. Doctors learned that Kleefstra syndrome can look different from one person to the next, even within the same family. Some children walk and talk later but steadily gain skills; others need ongoing support with mobility, communication, or behavior. Recognizing this range helped shift the historical view away from a single “typical” picture to a broader, more accurate understanding.
Looking back helps explain why some adults only received a diagnosis after their child was tested. Earlier generations did not have access to today’s genetic tools, so many lived without a name for their symptoms. As testing improved—from chromosome studies to microarray and gene sequencing—diagnoses increased, and the natural history of Kleefstra syndrome became clearer.
Today’s understanding stands on decades of clinic notes, family stories, and modern genetics. Despite evolving definitions, the central thread remains steady: identifying the underlying genetic change has transformed how Kleefstra syndrome is recognized, how early symptoms of Kleefstra syndrome are interpreted, and how care teams tailor support across childhood and adulthood.